Tablet formulation for CGRP active compounds | Patent Number 11925709

US 11925709 B2
Application Number17110398
Publication NumberUS 20210085612 A1
Pendency3 years, 3 months, 10 days
Filled DateDec 3, 2020
Priority DateFeb 5, 2014
Publication DateMar 25, 2021
Expiration DateFeb 4, 2034
Inventor/ApplicantsParesh B. Patel
Wei Xu
Hanmi Xi
Leonardo Resende Allain
Melanie Marota
Francis J. Flanagan, Jr.
Mary Ann Johnson
Francis J. Flanagan, JR.
Rebecca Nofsinger
Lisa Lupton
Chad D. Brown
W. Mark Eickhoff
Craig B. Ikeda
ExaminesDRAPER, LESLIE A ROYDS
Art Unit1629
Technology Center1600
Assignments
Merck Sharp & Dohme
Current
Merck Sharp & DohmeMerck & Co. Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.